Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Semin Thorac Cardiovasc Surg. 2021;33(2):454-458. doi: 10.1053/j.semtcvs.2020.09.005. Epub 2020 Sep 23.
The Fontan is the final common pathway for most single ventricle lesions. It is not a durable circulation and many Fontan patients eventually present for advanced heart failure therapies including mechanical circulatory support. While there have been advancements in available durable devices, many pediatric patients have size, anatomical, and physiologic constraints that make placement of adult ventricular assist devices challenging. And, Fontan failure comes in different varieties, including failure with preserved systolic function. This subset of patients requires either a subpulmonary assist device or a total artificial heart. Unique operative maneuvers, including atrial cannulation and atrioventricular valve manipulation have allowed many failing Fontan patients to be bridged to transplant after recovery of end-organ dysfunction and improved nutrition. The Advanced Cardiac Therapies Improving Outcomes Network is a multicenter learning network of pediatric hospitals implanting, managing, and studying ventricular assist devices in children and adults with congenital heart disease. This network is advancing the knowledge of outcomes and approaches to mechanical circulatory support in those with congenital heart disease, including Fontans. The congenital heart disease community continues to work toward and hope for a smaller durable device that will help this complex cohort of patients.
Fontan 是大多数单心室病变的最终共同途径。它不是一种持久的循环,许多 Fontan 患者最终需要接受先进的心力衰竭治疗,包括机械循环支持。虽然现有的耐用设备已经取得了进展,但许多儿科患者的体型、解剖结构和生理限制使得成人心室辅助设备的放置具有挑战性。而且,Fontan 衰竭有不同的类型,包括伴有收缩功能保留的衰竭。这组患者需要亚肺动脉辅助装置或全人工心脏。独特的手术操作,包括心房插管和房室瓣操作,使许多功能衰竭的 Fontan 患者在恢复终末器官功能和改善营养后,能够过渡到移植。先进的心脏治疗改善结局网络是一个多中心学习网络,由植入、管理和研究儿童和成人先天性心脏病患者心室辅助装置的儿科医院组成。该网络正在推进对先天性心脏病患者机械循环支持的结局和方法的认识,包括 Fontan 患者。先天性心脏病界继续努力并希望有一种更小的耐用设备,以帮助这一复杂的患者群体。